Algorithm predicts cartilage degeneration leading to osteoarthritis

Researchers from the University of Eastern Finland have developed a cartilage degenerative algorithm capable of predicting the progression of osteoarthritis in patients. The findings were published in Scientific Reports.

Detecting osteoarthritis (OA), the deterioration of articular cartilage, involves MRI or x-ray testing which can financially burden patients and fail to provide data on the risk of OA in its progression. This cartilage degeneration algorithm aims to predict OA progression to offer patients and providers with a comprehensive view to treat their OA.

The study applied the algorithm to 21 patients, who were OA-free at baseline, and put them into groups of patients with OA, patients with mild OA and patients with severe OA. After a four-year follow-up, researchers compared follow-up data to the algorithms predictions and found the algorithm was able to categorize patients in their correct groups.

Researcher hope the algorithm could assist patients as a clinical decision-making tool in personalizing treatment.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.